Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
A STAT3/integrin axis accelerates pancreatic cancer initiation and progression
Alejandro D Campos1, Ryan M Shepard1, Zachary Ortega1
1Department of Pathology, Moores Cancer Center at the University of California San Diego, La Jolla, San Diego, CA, USA; Department of Pathology, Sanford Consortium for Regenerative Medicine at the University of California San Diego, La Jolla, San Diego, CA, USA.
The STAT3 pathway drives pancreatic cancer progression. Researchers identified ITGB3 as a key gene regulated by STAT3, promoting tumor growth and potentially stratifying patients for targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The signal transducer and activator of transcription 3 (STAT3) pathway is crucial in pancreatic ductal adenocarcinoma (PDAC) progression.
- STAT3 coordinates cellular responses to stress and inflammation, significantly impacting tumor development.
Purpose of the Study:
- To identify STAT3-regulated genes involved in PDAC progression and poor survival.
- To elucidate the regulatory mechanisms of STAT3 in PDAC.
- To discover novel therapeutic targets and patient stratification strategies for PDAC.
Main Methods:
- ChIP-sequencing (ChIP-seq) on PDAC cells under hypoxia or oncostatin-M treatment.
- Single-cell transcriptomics to analyze gene expression in stressed PDAC cells.
- Chromatin accessibility assays to study gene regulation.
Main Results:
- Phospho-STAT3 binds to regulatory sites of genes linked to poor survival, with ITGB3 identified as a key driver of PDAC initiation and progression.
- ITGB3 expression is enriched in PDAC cells under oxidative stress from chemotherapy and correlates with STAT3 signaling, hypoxia, and the basal subtype.
- Chromatin accessibility at ITGB3 enhancers modulates STAT3-induced expression, revealing a plastic regulatory mechanism. An 18-gene signature was identified for survival stratification.
Conclusions:
- STAT3-mediated regulation of ITGB3 and other adaptive response genes offers a novel mechanism for PDAC progression.
- The identified 18-gene signature can stratify PDAC patient survival outcomes.
- These findings present opportunities for stratifying PDAC subpopulations for STAT3-targeted therapies.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

